The interaction between neurotrophins and glucocorticoids has been at the center of studies of neuroplasticity in stress-related disorders for several decades (1). The report in PNAS by shows that brainderived neurotrophic factor (BDNF) facilitates glucocorticoid receptor (GR)-mediated signaling and enables glucocorticoids, primed by BDNF, to activate gene transcription and possibly other cellular actions mediated by the GR. As a first step, according to ArangoLievano et al., glucocorticoids allow the detachment of the protein phosphatase, PP5, from GR complexes, permitting increased GR phosphorylation by MAP kinases. Then, the coincidence of BDNF and glucocorticoids is necessary to activate genomic GR responses because GR is not translocated into the nucleus of neurons stimulated only with BDNF, without the glucocorticoid being present.The Arango-Lievano et al. (2) paper "closes a loop" that was begun by a previous study by Jeanneteau, Garabedian, and Chao (3), showing that glucocorticoids can selectively activate tropomyosin receptor kinase B (TrkB) after in vivo administration in the brain and in cultures of hippocampal and cortical neurons. This activation did not require increased production of BDNF and was dependent on the genomic action of the GR. Thus, there is a positive feedback loop in which glucocorticoids and BDNF synergistically potentiate each other's concurrent actions, and Arango-Lievano et al. (2) suggest that failure of this loop underlies loss of plasticity and resilience in mood-related disorders, and possibly also the lack of response to antidepressant medications (Fig. 1). Taken together with other recent work on hormone action, this paper illustrates a number of important emerging themes concerning the positive and modulatory actions of glucocorticoids, as well as other steroid hormones, together with other signaling pathways, on a large number of important cellular processes in neural cells and the capacity of the adult, as well as the developing brain, for adaptive plasticity and resilience in the face of stress.The first theme is that we now recognize interconnections among steroid hormone actions on gene expression with other actions of these same hormones, as well as other modulators, that involve cellular signaling pathways at or near the cell surface. In the 1960s, steroid hormone receptors were recognized that regulate gene expression in the cell nucleus (4), and neurotransmitters and neuromodulators were shown to operate at or near the cell surface to regulate signaling pathways in which phosphorylation was a key element (5). However, we know now that nuclear and cellular signaling pathways interact in many ways. For example, dopamine activates progestin receptors in a ligand-independent manner and facilitates estrogen-primed lordosis behavior in the female rat in the absence of progesterone (6). Fig. 1. Glucocorticoids produce direct and indirect genomic actions as well as nongenomic signaling actions via glucocorticoid (GR) and mineralocorticoid (MR) receptors. These involve n...